Effect of +36T > C in intron 1 on the glutamine: Fructose-6-phosphate amidotransferase 1 gene and its contribution to type 2 diabetes in different populations

Journal of Human Genetics

Volumn 51, Issue 12, 2006, Pages 1100-1109

  Kunika, Kiyoshi ^a   Tanahashi, Toshihito ^a   Kudo, Eiji ^a   Mizusawa, Noriko ^a   Ichiishi, Eiichiro ^b   Nakamura, Naoto ^c   Yoshikawa, Toshikazu ^c   Yamaoka, Takashi ^d   Yasumo, Hiroaki ^e   Tsugawa, Kazue ^a   Moritani, Maki ^a   Inoue, Hiroshi ^a   Itakura, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Yamaoka Clinic   (Japan)

^e DAIICHI SANKYO CO   (Japan)

Author keywords

Association study; Caucasian; GFPT1; Japanese; Promoter activity; Type 2 diabetes

Indexed keywords

CYTOSINE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; LUCIFERASE; THYMINE;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL CELL; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; COMPUTER SIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; EXON; FEMALE; GC RICH SEQUENCE; GENE; GENE ACTIVITY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GFPT1 GENE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOUSE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; START CODON;

5' FLANKING REGION; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HUMANS; INTRONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 33751304131     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-006-0072-7     Document Type: Article

References (34)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
2. Balkan B, Dunning BE (1994) Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 43:1173-1179
3. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT (1995) Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. J Clin Invest 96:2792-2801
4. Border WA (1994) Transforming growth factor-beta and pathogenesis of glomerular disease. Curr Opin Nephrol Hypertens 3:54-58
5. Burt D, Brodbeck K, Haring HU, Schleicher ED, Weigert C (2005) Partial characterization of the human GFAT promoter: effect of single nucleotide polymorphisms on promoter function. Biochim Biophys Acta 1740:85-90
6. Buse MG (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290:E1-E8
7. Chan GC, Lernmark U, Xia Z, Storm DR (2001) DNA elements of the type 1 adenylyl cyclase gene locus enhance reporter gene expression in neurons and pinealocytes. Eur J Neurosci 13:2054-2066
8. Crook ED, McClain DA (1996) Regulation of glycogen synthase and protein phosphatase-1 by hexosamines. Diabetes 45:322-327
9. DeHaven JE, Robinson KA, Nelson BA, Buse MG (2001) A novel variant of glutamine:fructose-6-phosphate amido-transferase-1 (GFPT1) mRNA is selectively expressed in striated muscle. Diabetes 50:2419-2424
10. Elbein SC, Zheng H, Jia Y, Chu W, Cooper JJ, Hale T, Zhang Z (2004) Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy. Mol Genet Metab 82:321-328
11. 2+ in differentiating neurons. J Neurochem 84:282-293
12. Hamada D, Takata Y, Osabe D, Nomura K, Shinohara S, Egawa H, Nakano S, Shinomiya F, Scafe CR, Reeve VM, Miyamoto T, Moritani M, Kunika K, Inoue H, Yasui N, Itakura M (2005) Association between single-nucleotide polymorphisms in the SEC8L1 gene, which encodes a subunit of the exocyst complex, and rheumatoid arthritis in a Japanese population. Arthritis Rheum 52:1371-1380
13. Hattersley AT, McCarthy MI (2005) A question of standards: what makes a good genetic association study? Lancet 366:1315-1323
14. Hebert LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu JS, Baron AD, McClain DA (1996) Overexpression of glutamine:fructose-6- phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936
15. Hudson TJ (2003) Wanted: regulatory SNPs. Nat Genet 33:439-440
16. Iwasaki N, Cox NJ, Wang YQ, Schwarz PE, Bell GI, Honda M, Imura M, Ogata M, Saito M, Kamatani N, Iwamoto Y (2003) Mapping genes influencing type 2 diabetes risk and BMI in Japanese subjects. Diabetes 52:209-213
17. Kato H, Nomura K, Osabe D, Shinohara S, Mizumori O, Katashima R, Iwasaki S, Nishimura K, Yoshino M, Kobori M, Ichiishi E, Nakamura N, Yoshikawa T, Tanahashi T, Keshavarz P, Kunika K, Moritani M, Kudo E, Tsugawa K, Takata Y, Hamada D, Yasui N, Miyamoto T, Shiota H, Inoue H, Itakura M (2006) Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. Genomics 87:446-458
18. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED (1998) High glucose-induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169
19. Marshall S, Bacote V, Traxinger RR (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J Biol Chem 266:4706-4712
20. Meyer J, Mai M, Ortega G, Mossner R, Lesch KP (2002) Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree. Schizophr Res 58:87-91
21. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, Froguel P (2002) Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 51:1247-1255
22. Moslehi R, Goldstein AM, Beerman M, Goldin L, Bergen AW (2003) A genome-wide linkage scan for body mass index on Framingham Heart Study families. BMC Genet 4(Suppl 1):S97
23. Nawata H, Shirasawa S, Nakashima N, Araki E, Hashiguchi J, Miyake S, Yamauchi T, Hamaguchi K, Yoshimatsu H, Takeda H, Fukushima H, Sasahara T, Yamaguchi K, Sonoda N, Sonoda T, Matsumoto M, Tanaka Y, Sugimoto H, Tsubouchi H, Inoguchi T, Yanase T, Wake N, Narazaki K, Eto T, Umeda F, Nakazaki M, Ono J, Asano T, Ito Y, Akazawa S, Hazegawa I, Takasu N, Shinohara M, Nishikawa T, Nagafuchi S, Okeda T, Eguchi K, Iwase M, Ishikawa M, Aoki M, Keicho N, Kato N, Yasuda K, Yamamoto K, Sasazuki T (2004) Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese. J Hum Genet 49:629-634
24. Ng DP, Walker WH, Chia KS, Choo S, Warram JH, Krolewski AS (2004) Scrutiny of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) locus reveals conserved haplotype block structure not associated with diabetic nephropathy. Diabetes 53:865-869
25. Niimi M, Ogawara T, Yamashita T, Yamamoto Y, Ueyama A, Kambe T, Okamoto T, Ban T, Tamanoi H, Ozaki K, Fujiwara T, Fukui H, Takahashi EI, Kyushiki H, Tanigami A (2001) Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle. J Hum Genet 46:566-571
26. Patti ME, Virkamaki A, Landaker EJ, Kahn CR, Yki-Jarvinen H (1999) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48:1562-1571
27. Prestridge DS (1995) Predicting Pol II promoter sequences using transcription factor binding sites. J Mol Biol 249:923-932
28. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
29. Rebbeck TR, Spitz M, Wu X (2004) Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5:589-597
30. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N, Japan Diabetes Complication Study Group (2003) Obesity and type 2 diabetes in Japanese patients. Lancet 361:85
31. Steinke V, Meyer J, Syagailo YV, Ortega G, Hameister H, Mossner R, Schmitt A, Lesch KP (2003) The genomic organization of the murine Mlc1 (Wkl1, KIAA0027) gene. J Neural Transm 110:333-343
32. Weigert C, Friess U, Brodbeck K, Haring HU, Schleicher ED (2003) Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta 1 and fibronectin expression in mesangial cells. Diabetologia 46:852-855
33. Weigert C, Thamer C, Brodbeck K, Guirguis A, Machicao F, Machann J, Schick F, Stumvoll M, Fritsche A, Haring HU, Schleicher ED (2005) The -913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. J Clin Endocrinol Metab 90:1639-1643
34. World Health Organization (1985) Diabetes mellitus: report of a WHO study group